import streamlit as st
import google.generativeai as genai

# --- ğŸ¥ å©¦ç™Œè‡¨åºŠå°èˆªèˆ‡å¯¦è­‰åœ–æ›¸é¤¨ (2026 æœ€çµ‚å…¨åŠŸèƒ½æ“´å……ç‰ˆ) ---
st.set_page_config(page_title="å©¦ç™Œè‡¨åºŠè©¦é©—å°èˆªç³»çµ±", layout="wide")

st.markdown("""
    <style>
    @import url('https://fonts.googleapis.com/css2?family=Noto+Sans+TC:wght@400;700;900&family=Roboto:wght@400;700;900&display=swap');
    
    /* === æ¥µè‡´ç·Šç·»åŒ– UI === */
    html, body, [class*="css"] {
        font-family: 'Noto Sans TC', 'Roboto', sans-serif;
        background-color: #F4F7F9;
        color: #1A1A1A;
        font-size: 19px !important;
        line-height: 1.1;
    }

    .main-title {
        font-size: 32px !important; font-weight: 900; color: #004D40;
        padding: 5px 0; border-bottom: 3px solid #4DB6AC; margin-bottom: 5px;
    }

    /* å¤§éšæ®µæ–¹å¡Šï¼šé«˜åº¦éš¨å…§å®¹æ’é–‹ */
    .big-stage-card {
        border-radius: 10px; padding: 0px; 
        box-shadow: 0 2px 10px rgba(0,0,0,0.08);
        border: 2px solid transparent;
        background: white; margin-bottom: 4px; overflow: hidden;
        height: auto !important;
    }
    .big-stage-header {
        font-size: 17px !important; font-weight: 900; color: white;
        padding: 5px; text-align: center; margin: 0 !important;
    }

    /* å­å€å¡Š (SoC èˆ‡åˆ†å­äºå‹)ï¼šç·Šè²¼æ¨™é¡Œ */
    .sub-block {
        margin: 2px 4px; padding: 4px;
        border-radius: 6px; background: #F8F9FA;
        border-left: 5px solid #546E7A;
    }
    .sub-block-title {
        font-size: 13px; font-weight: 900; color: #37474F;
        margin-bottom: 1px; border-bottom: 1.1px solid #CFD8DC; padding-bottom: 1px;
    }
    .sub-block-content {
        font-size: 14px; color: #263238; font-weight: 500; line-height: 1.15;
        margin-bottom: 2px;
    }

    /* éšæ®µé¡è‰²å®šç¾© */
    .card-p-tx { border-color: #2E7D32; }
    .header-p-tx { background: linear-gradient(135deg, #43A047, #2E7D32); }
    .card-p-mt { border-color: #1565C0; }
    .header-p-mt { background: linear-gradient(135deg, #1E88E5, #1565C0); }
    .card-r-tx { border-color: #E65100; }
    .header-r-tx { background: linear-gradient(135deg, #FB8C00, #E65100); }
    .card-r-mt { border-color: #6A1B9A; }
    .header-r-mt { background: linear-gradient(135deg, #8E24AA, #6A1B9A); }

    /* --- æ¨™è¨˜æŒ‰éˆ•ï¼šæ·±é»‘è‰²å­—é«” (#1A1A1A) èˆ‡ é«˜å°æ¯”æ·ºåº•é…è‰² --- */
    .stPopover button { 
        font-weight: 900 !important; font-size: 12px !important; 
        border-radius: 4px !important; margin-top: 1px !important;
        padding: 1px 6px !important; width: 100% !important; 
        text-align: left !important; color: #1A1A1A !important; 
        border: 1px solid rgba(0,0,0,0.15) !important;
        box-shadow: 0 1px 3px rgba(0,0,0,0.1) !important;
    }
    
    /* ğŸ“š å·²ç™¼è¡¨å¯¦è­‰ (Milestone) è‰²å½© */
    .stPopover button[aria-label*="ğŸ“š"] { background: #ECEFF1 !important; border-left: 5px solid #455A64 !important; }

    /* ğŸ“ æ‹›å‹Ÿä¸­è©¦é©— (Ongoing) è—¥å» é…è‰²é£¾é‚Š */
    .stPopover button[aria-label*="Eli Lilly"] { background: #FCE4EC !important; border-left: 5px solid #E91E63 !important; } 
    .stPopover button[aria-label*="Daiichi Sankyo"] { background: #E8F5E9 !important; border-left: 5px solid #4CAF50 !important; } 
    .stPopover button[aria-label*="MSD"] { background: #E3F2FD !important; border-left: 5px solid #1976D2 !important; } 
    .stPopover button[aria-label*="AstraZeneca"] { background: #F3E5F5 !important; border-left: 5px solid #8E24AA !important; } 
    .stPopover button[aria-label*="GSK"] { background: #FFF3E0 !important; border-left: 5px solid #F57C00 !important; } 
    .stPopover button[aria-label*="Gilead"] { background: #E1F5FE !important; border-left: 5px solid #03A9F4 !important; } 
    .stPopover button[aria-label*="Seagen"] { background: #EEEEEE !important; border-left: 5px solid #212121 !important; } 

    .detail-section { background: white; border-radius: 18px; padding: 25px; border: 1px solid #CFD8DC; box-shadow: 0 10px 40px rgba(0,0,0,0.05); }
    .hr-big-val { font-family: 'Roboto', sans-serif; font-size: 50px !important; font-weight: 900; color: #D84315; }
    </style>
    """, unsafe_allow_html=True)

# --- 1. æŒ‡å¼•èˆ‡åˆ†å­è·¯å¾‘å¤§ç¶± ---
guidelines_nested = {
    "Endometrial": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "POLEmut (è¶…çªè®Šå‹)", "content": "é å¾Œæ¥µä½³ã€‚æ—©æœŸå¯è€ƒæ…®æ²»ç™‚é™éš (De-escalation)ï¼Œé¿å…æ”¾åŒ–ç™‚ä¹‹æ¯’æ€§ã€‚"},
            {"title": "MMRd / MSI-H", "content": "å…ç–«é«˜åº¦æ•æ„Ÿã€‚æ™šæœŸä¸€ç·šæ–¹æ¡ˆï¼šChemo + PD-1 (GY018/RUBY) ç²ç›Šé¡¯è‘—ã€‚"},
            {"title": "p53abn (Copy-number high)", "content": "ä¾µè¥²æ€§æœ€å¼·ã€‚æ—©æœŸå»ºè­°å‡ç´šæ²»ç™‚ï¼›Serous éœ€é©— HER2ã€‚"},
            {"title": "NSMP (æœ€å¤§å®—äºå‹)", "content": "<span style='color:#6A1B9A; font-weight:800;'>åˆ†å­åˆ¤å®šï¼šIHC MMR Intact / p53 wt / POLE wtã€‚</span><br>1. åˆ†å±¤é—œéµï¼šé å¾Œå–æ±ºæ–¼ ER ç‹€æ…‹ã€Grade 3 èˆ‡æ˜¯å¦å­˜åœ¨é¡¯è‘— LVSIã€‚<br>2. æ±ºç­–é‡é»ï¼šNSMP ER-negative å±¬é«˜é¢¨éšªï¼›ER-positive ä¸”é€²å±•æ…¢è€…å¯è€ƒæ…®è·çˆ¾è’™æ²»ç™‚ (Progestin/AI)ã€‚"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [{"title": "IO Maintenance", "content": "ä¸€ç·š Chemo-IO å¾Œï¼Œå»¶çºŒ IO ç¶­æŒç›´è‡³é€²å±• (PD)ã€‚"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [{"title": "MMRd / MSI-H", "content": "PD-1 æŠ‘åˆ¶åŠ‘å–®è—¥é«˜åæ‡‰ã€‚"}, {"title": "pMMR / NSMP", "content": "æ¨™æº–äºŒç·šæ–¹æ¡ˆï¼šPembrolizumab + Lenvatinib (SoC)ã€‚"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Continuous Therapy", "content": "ç¶­æŒç•¶å‰æœ‰æ•ˆæ¨™é¶/å…ç–«æ–¹æ¡ˆã€‚"}]}
    ],
    "Ovarian": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "HGSC / Endometrioid", "content": "Surgery + Carboplatin/Paclitaxel x6 Â± Bevacizumab"},
            {"title": "Mucinous (MOC) é‘‘åˆ¥", "content": "1. åˆ¤å®šï¼šCK7+/SATB2-ã€‚ 2. å‹æ…‹ï¼šExpansile (æ—©æœŸå¯ä¿å®ˆ) vs Infiltrative (é«˜å¾©ç™¼é¢¨éšª)ã€‚"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [
            {"title": "BRCA mutated", "content": "Olaparib å–®è—¥æˆ– Olaparib+Bev (è‹¥å«Bevå²)"},
            {"title": "HRD positive (wt)", "content": "å„ªå…ˆé¸ç”¨ Olaparib+Bev æˆ– Niraparib å–®è—¥ç¶­æŒ"},
            {"title": "HRD negative / pHRD", "content": "æœ‰ç”¨ Bev å‰‡çºŒç”¨ï¼›æœªç”¨å‰‡è§€å¯Ÿï¼Œè¦–é¢¨éšªè©•ä¼° Niraparib"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [
            {"title": "PSOC / PROC åˆ†æµ", "content": "ä¾ PFI åˆ¤å®šã€‚æ¨™é¶æª¢æ¸¬çœ‹ FRÎ± æˆ– HER2ã€‚"},
            {"title": "MOC æ™šæœŸ/å¾©ç™¼", "content": "åŒ–ç™‚æŠ—æ€§å¼·ã€‚è€ƒæ…® GI-like æ–¹æ¡ˆã€Trial æˆ–æŠ— HER2ã€‚"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Platinum Sensitive", "content": "æ•‘æ´ç·©è§£å¾Œé¸ PARPi ç¶­æŒæ²»ç™‚ã€‚"}]}
    ],
    "Cervical": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "Early (Surgery)", "content": "å‚³çµ±é–‹è…¹æ ¹æ²»è¡“ (LACCè©¦é©—)ã€‚ä½é¢¨éšªè€…å¯è€ƒæ…® SHAPE è©¦é©—ä¹‹å–®ç´”å…¨å­å®®åˆ‡é™¤ã€‚"},
            {"title": "CCRT (LA / 1L)", "content": "åŒæ­¥åŒ–æ”¾ç™‚ (CCRT)ã€‚é«˜é¢¨éšªè€…è€ƒæ…®åŒæ­¥ IO (KEYNOTE-A18) æˆ–èª˜å°åŒ–ç™‚ (INTERLACE)ã€‚"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [{"title": "Metastatic IO Maint", "content": "è½‰ç§»æ€§ä¸€ç·šå¾Œå»¶çºŒ Pembro ç¶­æŒç›´åˆ° PD"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [
            {"title": "1L Recurrent", "content": "Pembro + åŒ–ç™‚ Â± Bev (CPSâ‰¥1)ã€‚"},
            {"title": "2L / 3L Therapy", "content": "Tivdak (Tisotumab vedotin) æˆ– Cemiplimab"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Continuous Therapy", "content": "æœ‰æ•ˆæ–¹æ¡ˆæŒçºŒçµ¦è—¥ç›´è‡³é€²å±•"}]}
    ]
}

# --- 2. å¯¦è­‰é‡Œç¨‹ç¢‘è³‡æ–™åº« (ğŸ“š Milestone Library - æ·±åº¦æ“´å……) ---
milestone_db = [
    # Endometrial
    {"cancer": "Endometrial", "pos": "P-TX", "sub_pos": ["MMRd / MSI-H"], "name": "ğŸ“š RUBY (Dostarlimab)", "drug": "Dostarlimab + CP", 
     "summary": "é‡Œç¨‹ç¢‘åˆ†æï¼šdMMR æ­»äº¡é¢¨éšªé¡¯è‘—é™ä½ 68% (HR 0.32)ã€‚å…¨äººç¾¤ mOS å¾ 28.2 å€‹æœˆå»¶é•·è‡³ 44.6 å€‹æœˆ (HR 0.69)ã€‚å°æ–¼ pMMR æ—ç¾¤åŠ å…¥ Niraparib ç¶­æŒå¯æå‡ PFSã€‚"},
    {"cancer": "Endometrial", "pos": "P-TX", "sub_pos": ["MMRd / MSI-H", "NSMP"], "name": "ğŸ“š NRG-GY018 (KEYNOTE-868)", "drug": "Pembrolizumab + CP", 
     "summary": "dMMR æ—ç¾¤ç–¾ç—…é€²å±•é¢¨éšªé™ä½ 70% (HR 0.30)ã€‚pMMR æ—ç¾¤åŒæ¨£å±•ç¤ºé¡¯è‘— PFS æ”¹å–„ (HR 0.54)ã€‚FDA æ–¼ 2024 å¹´æ ¸å‡†ç”¨æ–¼æ‰€æœ‰æ™šæœŸæ‚£è€…ã€‚"},
    {"cancer": "Endometrial", "pos": "P-MT", "sub_pos": ["IO Maintenance"], "name": "ğŸ“š DUO-E", "drug": "Durvalumab +/- Olaparib", 
     "summary": "pMMR æ—ç¾¤äº®é»ï¼šDurvalumab+Olaparib ä¸‰è—¥è¯åˆå°‡ PFS HR é™è‡³ 0.57ï¼Œå„ªæ–¼å–®ç”¨ IOã€‚æç¤º PARP æŠ‘åˆ¶åŠ‘åœ¨ pMMR æ‚£è€…ä¸­å…·æœ‰å”åŒæ•ˆæ‡‰ã€‚"},
    {"cancer": "Endometrial", "pos": "R-TX", "sub_pos": ["pMMR / NSMP"], "name": "ğŸ“š KEYNOTE-775", "drug": "Pembro + Lenvatinib", 
     "summary": "ç¢ºç«‹äºŒç·šæ¨™æº–ï¼š5å¹´è¿½è¹¤é¡¯ç¤º pMMR æ‚£è€… OS ç²ç›ŠæŒä¹… (16.7% vs 7.3%)ã€‚"},
    
    # Ovarian
    {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["BRCA mutated"], "name": "ğŸ“š SOLO-1 (Olaparib)", "drug": "Olaparib", 
     "summary": "7å¹´è¿½è¹¤æ•¸æ“šï¼šå¯¦é©—çµ„ä»æœ‰ 67% æ‚£è€…å­˜æ´»ï¼ŒPFS HR 0.33ï¼Œé¡¯ç¤ºå°æ–¼ BRCAm æ‚£è€…å…·å‚™æ½›åœ¨ã€Œæ²»ç™’ã€èƒ½åŠ›ã€‚"},
    {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["HRD positive (wt)"], "name": "ğŸ“š PAOLA-1", "drug": "Olaparib + Bevacizumab", 
     "summary": "HRD+ æ—ç¾¤ (ç„¡è«– BRCA) ç²ç›Šæœ€å¤§ï¼Œ5å¹´ OS é¡¯è‘—æ”¹å–„ (HR 0.62)ã€‚å°æ–¼ HRD- æ‚£è€…åŠ å…¥ Olaparib ç„¡é¡å¤–å¥½è™•ã€‚"},
    {"cancer": "Ovarian", "pos": "R-TX", "sub_pos": ["PSOC / PROC åˆ†æµ"], "name": "ğŸ“š MIRASOL", "drug": "Mirvetuximab Soravtansine", 
     "summary": "PROC æ­·å²çªç ´ï¼šé¦–å€‹è­‰æ˜åœ¨ FRÎ± é«˜è¡¨ç¾ PROC æ‚£è€…ä¸­é¡¯è‘—å»¶é•· OS (HR 0.67) çš„ ADC è©¦é©—ã€‚"},
    {"cancer": "Ovarian", "pos": "P-TX", "sub_pos": ["HGSC / Endometrioid"], "name": "ğŸ“š DESKTOP III", "drug": "Secondary Cytoreduction", 
     "summary": "ç¬¦åˆ AGO Score çš„ PSOC æ‚£è€…é€²è¡ŒäºŒæ¬¡æ¸›ç©æ‰‹è¡“é¡¯è‘—å»¶é•· mOS è‡³ 53.7 å€‹æœˆ (vs 46.0m)ã€‚"},

    # Cervical
    {"cancer": "Cervical", "pos": "P-TX", "sub_pos": ["CCRT (LA / 1L)"], "name": "ğŸ“š KEYNOTE-A18", "drug": "Pembrolizumab + CCRT", 
     "summary": "LACC æ–°æ¨™æº–ï¼š36å€‹æœˆç¸½é«”å­˜æ´»ç‡æå‡è‡³ 82.6% (HR 0.67)ï¼Œæ­»äº¡é¢¨éšªé™ä½ 33%ã€‚"},
    {"cancer": "Cervical", "pos": "P-TX", "sub_pos": ["CCRT (LA / 1L)"], "name": "ğŸ“š INTERLACE", "drug": "Induction Chemotherapy", 
     "summary": "è€è—¥æ–°ç”¨åƒ¹å€¼ï¼šæ¨™æº– CCRT å‰åŠ  6é€±èª˜å°åŒ–ç™‚é¡¯è‘—æå‡ 5å¹´ OS (HR 0.60)ã€‚"},
    {"cancer": "Cervical", "pos": "P-TX", "sub_pos": ["Early (Surgery)"], "name": "ğŸ“š LACC Trial", "drug": "MIS vs Open", 
     "summary": "å…¸ç¯„è½‰ç§»ï¼šå¾®å‰µæ‰‹è¡“å¾©ç™¼/æ­»äº¡ç‡é¡¯è‘—è¼ƒé«˜ (HR 6.00)ï¼Œå°‡é–‹è…¹æ‰‹è¡“é‡æ–°ç¢ºç«‹ç‚ºæ ¹æ²»æ¨™æº–ã€‚"},
    {"cancer": "Cervical", "pos": "P-TX", "sub_pos": ["Early (Surgery)"], "name": "ğŸ“š SHAPE Trial", "drug": "Simple Hysterectomy", 
     "summary": "é™éšç­–ç•¥ï¼šé‡å°è…«ç˜¤ <2cm ä½é¢¨éšªè€…ï¼Œå–®ç´”åˆ‡é™¤åœ¨å¾©ç™¼ç‡ä¸Šä¸åŠ£æ–¼æ ¹æ²»è¡“ï¼Œä¸”å‰¯ä½œç”¨è¼ƒä½ã€‚"},
]

# --- 3. é€²è¡Œä¸­è‡¨åºŠè©¦é©—è³‡æ–™åº« (ğŸ“ Ongoing Trials - 8 æ ¸å¿ƒ) ---
ongoing_trials = [
    {"cancer": "Ovarian", "name": "FRAmework-01 (LY4170156)", "pharma": "Eli Lilly", "drug": "LY4170156 + Bev", "pos": "R-TX", "sub_pos": ["PSOC / PROC åˆ†æµ"], 
     "rationale": "æ¨™é¶ FRÎ± ADCï¼Œæ­è¼‰é¡å¾®ç®¡è›‹ç™½è¼‰è·ã€‚è¯ç”¨ Bevacizumab å¯ç”¢ç”Ÿè¡€ç®¡èª¿ç¯€å”åŒä½œç”¨ (Synergy)ï¼Œæå‡ ADC æ»²é€ä¸¦é€éæ—è§€è€…æ•ˆæ‡‰ (Bystander Effect) æ®ºå‚·ç•°è³ªæ€§è…«ç˜¤ï¼Œå°ˆæ”» PARPi è€è—¥å¾Œéœ€æ±‚ã€‚",
     "dosing": {"Exp Arm (Part A/B)": "LY4170156 3 mg/kg IV + Bevacizumab 15 mg/kg IV Q3Wã€‚", "Control A (PROC)": "TPC (Pacli/PLD/Gem/Top) æˆ– MIRVã€‚", "Control B (PSOC)": "Standard Platinum doublet + Bev 15 mg/kg Q3Wã€‚"},
     "outcomes": {"ORR": "Ph 1/2: ~35-40%", "HR": "Phase 3 Ongoing", "CI": "NCT06536348"},
     "inclusion": ["HG Serous / Carcinosarcoma ä¹‹åµå·¢/è¼¸åµç®¡ç™Œã€‚", "FRÎ± Expression Positive (ä¸­å¤®å¯¦é©—å®¤æª¢æ¸¬)ã€‚", "Part A (PROC): æœ€å¾Œä¸€åŠ‘é‰‘é¡å¾Œ 90â€“180 å¤©æƒ¡åŒ–ã€‚", "Part B (PSOC): æœ€å¾Œä¸€åŠ‘é‰‘é¡å¾Œ >180 å¤©æƒ¡åŒ–ä¸”æ›¾ç”¨é PARPiã€‚"],
     "exclusion": ["å…ˆå‰ç”¨é Topo I ADC (å¦‚ Enhertu)ã€‚", "å…·æœ‰è‡¨åºŠé¡¯è‘—è›‹ç™½å°¿ (UPCR â‰¥ 2.0)ã€‚", "æ´»å‹•æ€§ ILD ç—…å²ã€‚"], "ref": "NCT06536348"},
    
    {"cancer": "Ovarian", "name": "REJOICE-Ovarian01", "pharma": "Daiichi Sankyo", "drug": "R-DXd", "pos": "R-TX", "sub_pos": ["PSOC / PROC åˆ†æµ"], 
     "rationale": "æ¨™é¶ CDH6 ADCï¼Œæ­è¼‰å¼·æ•ˆ DXd è¼‰è·ã€‚å…·å‚™æ¥µé«˜ DAR (8) èˆ‡å¼·åŠ›æ—è§€è€…æ•ˆæ‡‰ï¼Œå°ˆæ”»é«˜åº¦ç•°è³ªæ€§çš„ PROC è…«ç˜¤ç’°å¢ƒï¼Œå…‹æœå‰ç·šåŒ–ç™‚è€è—¥æ€§ä¸¦æ”¹å–„ç”Ÿå­˜ã€‚",
     "dosing": {"Exp Arm": "R-DXd 5.6mg/kg IV Q3Wã€‚", "Control Arm": "Investigator's Choice å–®è—¥åŒ–ç™‚ (Paclitaxel/PLD/Topotecan)ã€‚"},
     "outcomes": {"ORR": "46.0% (Ph1 Update)", "mPFS": "7.1m", "HR": "Phase 3", "CI": "NCT06161025"},
     "inclusion": ["HG Serous æˆ– Endometrioid PROC åµå·¢ç™Œã€‚", "æ›¾æ¥å—é 1-4 ç·šç³»çµ±æ€§æ²»ç™‚ã€‚", "éœ€æ›¾ç”¨é Bevacizumab (é™¤éæœ‰ç¦å¿Œç—‡)ã€‚"],
     "exclusion": ["Low-grade è…«ç˜¤ã€‚", "å…·æœ‰ ILD è‚ºéƒ¨ç—…å²æˆ–ç–‘ä¼¼ç—‡ç‹€ã€‚", "LVEF < 50%ã€‚"], "ref": "JCO 2024"},
    
    {"cancer": "Ovarian", "name": "TroFuse-021 (MK-2870)", "pharma": "MSD", "drug": "Sac-TMT", "pos": "P-MT", "sub_pos": ["HRD negative / pHRD"], 
     "rationale": "æ¨™é¶ Trop-2 ADCã€‚çµåˆ Beva å¾®ç’°å¢ƒèª¿ç¯€èˆ‡ ADC èª˜å°çš„ ICD æ•ˆæ‡‰ï¼Œæ—¨åœ¨å„ªåŒ– pHRD æ—ç¾¤åœ¨ä¸€ç·šç¶­æŒæ™‚çš„ç²ç›Šï¼Œå¡«è£œ PARPi åæ‡‰ä¸è¶³ä¹‹éœ€æ±‚ã€‚",
     "dosing": {"Arm 1": "Sac-TMT å–®è—¥ç¶­æŒã€‚", "Arm 2": "Sac-TMT + Beva 15mg/kg Q3Wã€‚", "Arm 3": "Observation / Bevacizumab ç¨è‡ªç¶­æŒã€‚"},
     "outcomes": {"ORR": "Est 40% (pHRD)", "mPFS": "æ‹›å‹Ÿä¸­", "HR": "Phase 3", "CI": "NCT06241729"},
     "inclusion": ["æ–°è¨ºæ–· FIGO III/IV åµå·¢ç™Œã€‚", "HRD negative (pHRD) ä¸” BRCA é‡ç”Ÿå‹ã€‚", "ä¸€ç·šå«é‰‘åŒ–ç™‚å¾Œé” CR æˆ– PR ç‹€æ…‹ã€‚"],
     "exclusion": ["BRCA çªè®Šæˆ– HRD é™½æ€§ã€‚", "åš´é‡ç‚ç—‡æ€§è…¸é“ç–¾ç—… (IBD)ã€‚", "å…ˆå‰ç”¨é Trop-2 ADCã€‚"], "ref": "ENGOT-ov85"},
    
    {"cancer": "Ovarian", "name": "DOVE (APGOT-OV07)", "pharma": "GSK", "drug": "Dostarlimab + Bev", "pos": "R-TX", "sub_pos": ["PSOC / PROC åˆ†æµ"], 
     "rationale": "é‡å°é€æ˜ç´°èƒç™Œ (OCCC) çš„å…ç–«æŠ‘åˆ¶ç’°å¢ƒã€‚åˆ©ç”¨ PD-1 é˜»æ–·èˆ‡ VEGF æŠ‘åˆ¶ä¹‹é›™é‡æ‰“æ“Šï¼Œæ¢å¾© T ç´°èƒæµ¸æ½¤ä¸¦èª˜ç™¼æ‡‰ç­”ã€‚",
     "dosing": {"Combo": "Dostarlimab 500mg Q3W x4 -> 1000mg Q6W + Bev Q3Wã€‚", "Control": "é†«å¸«é¸æ“‡å–®è—¥åŒ–ç™‚ (Gem/PLD/Taxel)ã€‚"},
     "outcomes": {"ORR": "40.2% (OCCC)", "mPFS": "8.2m", "HR": "0.58", "CI": "NCT06023862"},
     "inclusion": ["çµ„ç¹”å­¸ OCCC > 50%ã€‚", "é‰‘é¡æŠ—è—¥æ€§ (æœ€å¾Œä¸€åŠ‘å¾Œ 12å€‹æœˆå…§å¾©ç™¼)ã€‚", "å…ˆå‰æ²»ç™‚ç·šæ•¸ â‰¤ 5 ç·šã€‚"],
     "exclusion": ["å…ˆå‰ç”¨éä»»ä½•å…ç–«æ²»ç™‚ã€‚", "è‡¨åºŠé¡¯è‘—è…¸é˜»å¡å²ã€‚"], "ref": "JCO 2025"},

    {"cancer": "Ovarian", "name": "DS8201-772 (Enhertu)", "pharma": "AstraZeneca", "drug": "T-DXd", "pos": "R-MT", "sub_pos": ["Platinum Sensitive"], 
     "rationale": "æ¨™é¶ HER2 ADC. ä½œç‚ºæ•‘æ´åŒ–ç™‚ç©©å®šå¾Œä¹‹ç²¾æº–ç¶­æŒé¦–é¸ã€‚è¶…é«˜ DAR (8) å„ªå‹¢èƒ½æœ‰æ•ˆæ¸…é™¤ HER2 è¡¨ç¾ç™Œç´°èƒä¹‹æ®˜ç•™ç—…ç¶ã€‚",
     "dosing": {"Standard": "T-DXd 5.4mg/kg IV Q3Wã€‚", "Combo": "T-DXd 5.4mg/kg + Beva 15mg/kg Q3Wã€‚"},
     "outcomes": {"ORR": "46.3% (IHC 3+)", "mPFS": "10.4m", "HR": "0.42", "CI": "NCT04482309"},
     "inclusion": ["HER2 IHC 1+/2+/3+ ç¢ºèªã€‚", "PSOC æ•‘æ´åŒ–ç™‚é”ç©©å®š (Non-PD)ã€‚", "LVEF â‰¥ 50%ã€‚"],
     "exclusion": ["ILD è‚ºéƒ¨ç—…å²ã€‚", "å…ˆå‰æ¥å—é HER2 ADCã€‚"], "ref": "JCO 2024"},

    {"cancer": "Endometrial", "name": "MK2870-033", "pharma": "MSD", "drug": "Sac-TMT + Pembro", "pos": "P-MT", "sub_pos": ["IO Maintenance", "NSMP (æœ€å¤§å®—äºå‹)"], 
     "rationale": "æ¨™é¶ Trop-2 ADC å”åŒ PD-1. é€éå…ç–«èª¿ç¯€å¼·åŒ– Pembrolizumab åœ¨ pMMR æˆ– NSMP æ—ç¾¤çš„é•·æœŸæ‡‰ç­”èˆ‡æŒçºŒç·©è§£ã€‚",
     "dosing": {"Induction": "Carbo+Pacli+Pembro Q3Wã€‚", "Maintenance": "Pembro 400 mg Q6W + Sac-TMT 5 mg/kg Q6Wã€‚"},
     "outcomes": {"ORR": "Est 35% Ph 2", "HR": "Ongoing", "CI": "NCT06132958"},
     "inclusion": ["pMMR å­å®®å…§è†œç™Œ (ä¸­å¿ƒæª¢æ¸¬)ã€‚", "FIGO III/IV ä¸€ç·šå«é‰‘+Pembroå¾Œé” CR/PRã€‚"],
     "exclusion": ["å­å®®è‚‰ç˜¤ (Sarcoma)ã€‚", "å…ˆå‰æ¥å—éæ™šæœŸç³»çµ±æ€§ IO æ²»ç™‚ã€‚"], "ref": "ESMO 2025"},
    
    {"cancer": "Endometrial", "name": "GU-US-682-6769", "pharma": "Gilead", "drug": "SG (Trodelvy)", "pos": "R-TX", "sub_pos": ["pMMR / NSMP", "p53abn (Copy-number high)"], 
     "rationale": "æ¨™é¶ Trop-2 ADC. åˆ©ç”¨ SN-38 è¼‰è·å¼•ç™¼ DNA æå‚·ï¼Œå°ˆæ”»é‰‘é¡èˆ‡å…ç–«å¤±æ•—å¾Œä¹‹äºŒ/ä¸‰ç·šæ•‘æ´ï¼Œå…·å‚™å¼·æ•ˆæ—è§€è€…æ•ˆæ‡‰ã€‚",
     "dosing": {"Exp": "SG 10mg/kg (D1, D8 Q21D)ã€‚", "Control": "TPC (Doxo/Taxel)ã€‚"},
     "outcomes": {"ORR": "28.5%", "mPFS": "5.6m", "HR": "0.64", "CI": "NCT03964727"},
     "inclusion": ["å¾©ç™¼æ€§ EC (éè‚‰ç˜¤)ã€‚", "é‰‘é¡èˆ‡ PD-1 å¤±æ•—å¾Œé€²å±•ã€‚"],
     "exclusion": ["å…ˆå‰ç”¨é Trop-2 ADCã€‚", "æ´»å‹•æ€§ CNS è½‰ç§»ã€‚"], "ref": "JCO 2024"},

    {"cancer": "Cervical", "name": "innovaTV 301", "pharma": "Seagen", "drug": "Tivdak", "pos": "R-TX", "sub_pos": ["2L / 3L Therapy"], 
     "rationale": "æ¨™é¶ Tissue Factor (TF) ADC. æ—¨åœ¨å…‹æœå¾Œç·šå­å®®é ¸ç™ŒåŒ–ç™‚è€è—¥æ€§ï¼Œæ”¹å–„ç”Ÿå­˜é å¾Œ (OS)ã€‚",
     "dosing": {"Exp Arm": "Tisotumab vedotin 2.0mg/kg Q3Wã€‚", "Control Arm": "é†«å¸«é¸æ“‡å–®è—¥åŒ–ç™‚ (TPC)ã€‚"},
     "outcomes": {"ORR": "17.8%", "mPFS": "4.2m", "HR": "0.70 (OS)", "CI": "NEJM 2024"},
     "inclusion": ["å¾©ç™¼/è½‰ç§»å­å®®é ¸ç™Œã€‚", "å…ˆå‰æ¥å— 1â€“2 ç·šæ²»ç™‚å¾Œé€²å±•ã€‚"],
     "exclusion": ["åš´é‡çœ¼ç–¾/è§’è†œç‚ã€‚", "æ´»å‹•æ€§å‡ºè¡€å‚¾å‘ã€‚"], "ref": "NEJM 2024"}
]

# --- 4. AI ç©©å®šæ¨¡å‹å·¡é‚é‚è¼¯ ---
def get_gemini_model():
    try:
        available_models = [m.name for m in genai.list_models() if 'generateContent' in m.supported_generation_methods]
        target_model = None
        for m in available_models:
            if 'gemini-1.5-flash' in m:
                target_model = m
                break
        if not target_model:
            for m in available_models:
                if 'gemini-1.5-pro' in m or 'gemini-pro' in m:
                    target_model = m
                    break
        if target_model: return genai.GenerativeModel(target_model)
    except: return None

# --- 5. å´é‚Šæ¬„ ---
if 'selected_trial' not in st.session_state:
    st.session_state.selected_trial = ongoing_trials[0]['name']

with st.sidebar:
    st.markdown("<h3 style='color: #6A1B9A;'>ğŸ¤– AI å¯¦è­‰åª’åˆåŠ©ç†</h3>", unsafe_allow_html=True)
    api_key = st.text_input("Gemini API Key", type="password")
    with st.expander("âœ¨ æ‚£è€…æ•¸æ“šæ·±åº¦åˆ†æ", expanded=True):
        p_notes = st.text_area("è¼¸å…¥ç—…æ­·æ‘˜è¦ (å«åˆ†å­/ç—…ç†)", height=250)
        if st.button("ğŸš€ é–‹å§‹åˆ†æ"):
            if api_key and p_notes:
                try:
                    genai.configure(api_key=api_key)
                    model = get_gemini_model()
                    if model:
                        prompt = f"åˆ†æç—…æ­·ï¼š{p_notes}ã€‚è«‹åƒè€ƒé‡Œç¨‹ç¢‘å¯¦è­‰ï¼š{milestone_db} èˆ‡æ‹›å‹Ÿä¸­è©¦é©—ï¼š{ongoing_trials}ã€‚æä¾›æœ€ä½³è·¯å¾‘å»ºè­°èˆ‡ç†ç”±ã€‚"
                        st.write(model.generate_content(prompt).text)
                    else: st.error("æ‰¾ä¸åˆ°å¯ç”¨ AI æ¨¡å‹ã€‚")
                except Exception as e: st.error(f"AI ç•°å¸¸: {e}")

# --- 6. ä¸»é é¢ï¼šç·Šæ¹Šå°èˆªå„€è¡¨æ¿ ---
st.markdown("<div class='main-title'>å©¦ç™Œè‡¨åºŠè©¦é©—å°èˆªå„€è¡¨æ¿ (æŒ‡å¼•å¯¦è­‰èˆ‡ç ”ç©¶æ•´åˆç‰ˆ)</div>", unsafe_allow_html=True)
cancer_type = st.radio("ç¬¬ä¸€æ­¥ï¼šé¸æ“‡ç™Œç—‡é¡å‹", ["Endometrial", "Ovarian", "Cervical"], horizontal=True)

st.subheader("ç¬¬äºŒæ­¥ï¼šé»æ“Š ğŸ“š å¯¦è­‰é‡Œç¨‹ç¢‘ æˆ– ğŸ“ æ‹›å‹Ÿä¸­è©¦é©— (èˆ‡ SoC åŒæ­¥å°ç…§)")
cols = st.columns(4)
stages_data = guidelines_nested[cancer_type]

for i, stage in enumerate(stages_data):
    with cols[i]:
        st.markdown(f"""<div class='big-stage-card card-{stage['css']}'><div class='big-stage-header header-{stage['css']}'>{stage['header']}</div>""", unsafe_allow_html=True)
        for sub in stage['subs']:
            st.markdown(f"""<div class='sub-block'><div class='sub-block-title'>ğŸ“˜ {sub['title']}</div><div class='sub-block-content'>{sub['content']}</div>""", unsafe_allow_html=True)
            
            # A. å¯¦è­‰é‡Œç¨‹ç¢‘ (ğŸ“š)
            rel_milestones = [m for m in milestone_db if m["cancer"] == cancer_type and m["pos"] == stage["id"] and any(s in sub["title"] for s in m["sub_pos"])]
            for m in rel_milestones:
                with st.popover(f"ğŸ“š {m['name']}", use_container_width=True):
                    st.success(f"**è—¥ç‰©:** {m['drug']}\n\n**é—œéµå¯¦è­‰:** {m['summary']}")
            
            # B. æ‹›å‹Ÿä¸­è©¦é©— (ğŸ“)
            rel_trials = [t for t in ongoing_trials if t["cancer"] == cancer_type and t["pos"] == stage["id"] and any(s in sub["title"] for s in t["sub_pos"])]
            for t in rel_trials:
                label = f"ğŸ“ {t['pharma']} | {t['name']} | {t['drug']}"
                ukey = f"btn_{t['name']}_{stage['id']}_{sub['title'].replace(' ', '')}"
                with st.popover(label, use_container_width=True):
                    st.markdown(f"#### âœ¨ {t['name']} æ‹›å‹Ÿè§£æ")
                    st.info(f"**Rationale:** {t['rationale'][:160]}...")
                    if st.button("ğŸ“Š é–‹å•Ÿæ·±åº¦åˆ†æå ±å‘Š", key=ukey):
                        st.session_state.selected_trial = t['name']
            st.markdown("</div>", unsafe_allow_html=True)
        st.markdown("</div>", unsafe_allow_html=True)

# --- 7. æ·±åº¦åˆ†æçœ‹æ¿ ---
st.divider()
t_options = [t["name"] for t in ongoing_trials if t["cancer"] == cancer_type]
if t_options:
    try: curr_idx = t_options.index(st.session_state.selected_trial)
    except: curr_idx = 0
    selected_name = st.selectbox("ğŸ¯ åˆ‡æ›æ‹›å‹Ÿä¸­è©¦é©—ä¹‹è©³ç´°å ±å‘Šï¼š", t_options, index=curr_idx)
    t = next(it for it in ongoing_trials if it["name"] == selected_name)

    st.markdown(f"<div class='detail-section'>", unsafe_allow_html=True)
    st.markdown(f"<h2 style='color:#004D40; border-bottom:3px solid #E0E0E0; padding-bottom:10px; font-weight:900;'>ğŸ“‹ {t['name']} æ‹›å‹Ÿä¸­è©¦é©—æ·±åº¦å ±å‘Š</h2>", unsafe_allow_html=True)

    r1, r2 = st.columns([1.3, 1])
    with r1:
        st.markdown("<div style='background:#E3F2FD; border-left:10px solid #1976D2; padding:15px; border-radius:10px;'><b>ğŸ’‰ Dosing Protocol & Rationale</b></div>", unsafe_allow_html=True)
        st.write(f"**æ ¸å¿ƒè—¥ç‰©:** {t['drug']}")
        for arm, details in t['dosing'].items(): st.write(f"ğŸ”¹ **{arm}**: {details}")
        st.markdown("---")
        st.success(f"**æ©Ÿè½‰å¯¦è­‰ (Rationale):** {t['rationale']}")
        

    with r2:
        st.markdown("<div style='background:#FFF8E1; border-left:8px solid #FBC02D; padding:15px; border-radius:10px;'><b>ğŸ“ˆ Efficacy & Outcomes (Ph1/2)</b></div>", unsafe_allow_html=True)
        st.markdown(f"""
            <div style='text-align:center; background:white; padding:15px; border:2px solid #FFE082; border-radius:12px;'>
                <div style='font-size: 14px; color: #795548; font-weight:700; margin-bottom:5px;'>Hazard Ratio (Expected) / NCT</div>
                <div class='hr-big-val'>{t['outcomes'].get('HR', 'Ongoing')}</div>
                <div style='font-size:18px; color:#5D4037; font-weight:700;'>{t['outcomes'].get('CI', t['outcomes'].get('CI', ''))}</div>
            </div>
        """, unsafe_allow_html=True)
        st.write(f"**ORR:** {t['outcomes'].get('ORR', 'TBD')} | **mPFS:** {t['outcomes'].get('mPFS', 'Ongoing')}")
        

    st.divider()
    r3, r4 = st.columns(2)
    with r3:
        st.markdown("<div style='background:#E8F5E9; border-left:8px solid #2E7D32; padding:15px; border-radius:10px;'><b>âœ… Inclusion Criteria (ç´å…¥æ¨™æº–)</b></div>", unsafe_allow_html=True)
        for inc in t.get('inclusion', []): st.write(f"â€¢ **{inc}**")
    with r4:
        st.markdown("<div style='background:#FFEBEE; border-left:8px solid #C62828; padding:15px; border-radius:10px;'><b>âŒ Exclusion Criteria (æ’é™¤æ¨™æº–)</b></div>", unsafe_allow_html=True)
        for exc in t.get('exclusion', []): st.write(f"â€¢ **{exc}**")
    st.markdown("</div>", unsafe_allow_html=True)
